In contrast, an inflammatory role of IL-22 was described in CRS, indicating that IL-22/IL-22Ra1 axis promotes thymic stromal lymphopoietin (TSLP) production under a type-2 microenvironment in airway epithelial cells, potentially contributing to the development of nasal polyps [60]. The gene discussed is IL22; the disease is Nasal polyposis.